TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes

EMBO Journal

Volumn 19, Issue 5, 2000, Pages 956-963

  Xiao, Hua ^a   Palhan, Vikas ^a   Yang, Yili ^b   Roeder, Robert G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Metastasis suppressor; SCLC; Tat; Transcription

Indexed keywords

PROTEIN SERINE THREONINE KINASE; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CANCER INHIBITION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVITY; GENE INDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034161272     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.5.956     Document Type: Article

References (46)

1. 1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma. Cell Growth Diff., 7, 879-886.
2. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K.C. (1995) Current Protocols in Molecular Biology. John Wiley & Sons Inc., New York, NY.
3. Baskaran, R., Chiang, G.G., Mysliwiec, T., Kruh, G.D. and Wang, J.Y. (1997) Tyrosine phosphorylation of RNA polymerase II carboxyl-terminal domain by the Abl-related gene product. J. Biol. Chem., 272, 18905-18909.
4. Bassuk, A.G., Anandappa, R.T. and Leiden, J.M. (1997) Physical interactions between Ets and NF-κ/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J. Virol., 71, 3563-3573.
5. Baker, M.E. (1999) TIP30, a cofactor for HIV-1 Tat-activated transcription, is homologous to short-chain dehydrogenases/reductases. Curr. Biol., 9, R471.
6. Benkirane, M., Chun, R.F., Xiao, H. Ogryzko, V.V., Howard, B.H., Nakatani, Y. and Jeang, K.T. (1998) Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem., 273, 24898-24905.
7. Bieniasz, P.D., Grdina, T.A., Bogerd, H.P. and Cullen, B.R. (1998) Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J., 17, 7056-7065.
8. Blau, J., Xiao, H., McCracken, S., O'Hare, P., Greenblatt, J. and Bentley, D. (1996) Three functional classes of transcriptional activation domain. Mol. Cell. Biol., 5, 2044-2055.
9. Bossemeyer, D. (1994) The glycine-rich sequence of protein kinases: a multifunctional element. Trends Biochem. Sci., 5, 201-205.
10. Chiang, C.M. and Roeder, R.G. (1993) Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution. Peptide Res., 6, 62-64.
11. Chun, R.F. and Jeang, K.T. (1996) Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J. Biol. Chem., 271, 27888-27894.
12. Cujec, T.P., Okamoto, H., Fujinaga, K., Meyer, J., Chamberlin, H., Morgan, D.O. and Peterlin, B.M. (1997) The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev., 11, 2645-2657.
13. Dahmus, M.E. (1995) Phosphorylation of the C-terminal domain of RNA polymerase II. Biochim. Biophys. Acta, 1261, 171-182.
14. Dragovich, T., Rudin, C.M. and Thompson, C.B. (1998) Signal transduction pathways that regulate cell survival and cell death. Oncogene, 17, 3207-3213.
15. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
16. Garber, M.E., Wei, P., Kewal Ramani, V.N., Mayall, T.P., Herrmann, C.H., Rice, A.P., Littman, D.R. and Jones, K.A. (1998) The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev., 12, 3512-3527.
17. Green, D.R. and Reed, J.C. (1998) Mitochondria and apoptosis. Science, 281, 1309-1312.
18. Hanks, S.K., Quinn, A.M. and Hunter, T. (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science, 241, 42-52.
19. Hermeking, H. and Eick, D. (1994) Mediation of c-Myc-induced apoptosis by p53. Science, 265, 2091-2093.
20. Hoffmann, A. and Roeder, R.G. (1996) Cloning and characterization of human TAF20/15. Multiple interactions suggest a central role in TFIID complex formation. J. Biol. Chem., 271, 18194-18202.
21. Hottiger, M.O. and Nabel, G.J. (1998) Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. Virology, 72, 8252-8256.
22. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature, 385, 544-548.
23. Liao, S.M., Zhang, J., Jeffery, D.A., Koleske, A.J., Thompson, C.M., Chao, D.M., Viljoen, M., van Vuuren, H.J. and Young, R.A. (1995) A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature, 374, 193-196.
24. Liu, Y., Thor, A., Shtivelman, E., Cao, Y., Tu, G., Heath, T.D. and Debs, R.J. (1999) Systemic gene delivery expands the repertoire of effective antiangiogenic agents sensitizing cell to apoptosis. J. Biol. Chem., 274, 13338-13344.
25. Lu, H., Zawel, L., Fisher, L., Egly, J.M. and Reinberg, D. (1992) Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature, 358, 641-645.
26. Mancebo, H.S. et al. (1997) P -TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev., 11, 2633-2644.
27. Marshall, N.F. and Price, D.H. (1995) Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem., 270, 12335-12338.
28. Marshall, N.F., Peng, J., Xie, Z. and Price, D.H. (1996) Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem., 271, 27176-27183.
29. Marzio, G., Tyagi, M., Gutierrez, M.I. and Giacca, M. (1998) HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl Acad. Sci. USA, 95, 2146-2151.
30. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
31. Ohkuma, Y. and Roeder, R.G. (1994) Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation complex formation. Nature, 368, 160-163.
32. Okamoto, H., Sheline, C.T., Corden, J.L., Jones, K.A. and Peterlin, B.M. (1996) Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl Acad. Sci. USA, 93, 11575-11579.
33. Parada, C.A. and Roeder, R.G. (1996) Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature, 384, 375-378.
34. Peng, J., Zhu, Y., Milton, J.T. and Price, D.H. (1998) Identification of multiple cyclin subunits of human P-TEFb. Genes Dev., 12, 755-762.
35. Peterson, S.R., Dvir, A., Anderson, C.W. and Dynan, W.S. (1992) DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats. Genes Dev., 6, 426-438.
36. Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W. and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature, 389, 300-305.
37. Postel, E.H., Berberich, S.J., Flint, S.J. and Ferrone, C.A. (1993) Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science, 261, 478-480.
38. Prasad, K.V., Ao, Z., Yoon, Y., Wu, M.X., Rizk, M., Jacquot, S. and Schlossman, S.F. (1997) CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl Acad. Sci. USA, 94, 6346-6351.
39. Shtivelman, E. (1997) A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene, 14, 2167-2173.
40. Steeg, P.S. (1989) Search for metastasis suppressor genes. Invasion Metastasis, 9, 351-359.
41. Vaux, D.L. and Korsmeyer, S.J. (1999) Cell death in development. Cell, 96, 245-254.
42. Wagner, A.J., Kokontis, J.M. and Hay, N. (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cipl. Genes Dev., 8, 2817-2830.
43. Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H. and Jones, K.A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell, 92, 451-462.
44. Xiao, H., Tao, Y., Greenblatt, J. and Roeder, R.G. (1998) A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc. Natl Acad. Sci. USA, 95, 13519-13524.
45. Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B. and Korsmeyer, S.J. (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285-291.
46. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M.B. and Price, D.H. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev., 11, 2622-2632.